Results of a Phase II clinical trial with Id-protein-loaded dendritic cell vaccine in multiple myeloma: encouraging or discouraging?
about
Antigen-loaded dendritic cell migration: MR imaging in a pancreatic carcinoma model.Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinomaChallenges in vaccine therapy in hematological malignancies and strategies to overcome them.Mouse dendritic cell migration in abdominal lymph nodes by intraperitoneal administration
P2860
Results of a Phase II clinical trial with Id-protein-loaded dendritic cell vaccine in multiple myeloma: encouraging or discouraging?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Results of a Phase II clinical ...... : encouraging or discouraging?
@en
Results of a Phase II clinical ...... : encouraging or discouraging?
@nl
type
label
Results of a Phase II clinical ...... : encouraging or discouraging?
@en
Results of a Phase II clinical ...... : encouraging or discouraging?
@nl
prefLabel
Results of a Phase II clinical ...... : encouraging or discouraging?
@en
Results of a Phase II clinical ...... : encouraging or discouraging?
@nl
P2093
P2860
P356
P1433
P1476
Results of a Phase II clinical ...... : encouraging or discouraging?
@en
P2093
Andreas Draube
Kerstin Wennhold
Maria A Garcia-Marquez
Michael von Bergwelt-Baildon
P2860
P304
P356
10.2217/IMT.12.94
P577
2012-10-01T00:00:00Z